Logo image
Back
Global pneumococcal sequence cluster lineage for invasive pneumococcal isolates in Denmark from summer 2019 to 2023
Journal article   Open access   Peer reviewed

Global pneumococcal sequence cluster lineage for invasive pneumococcal isolates in Denmark from summer 2019 to 2023

Hans-Christian Slotved, Thor Bech Johannesen, Marc Stegger and Kurt Fuursted
Scientific reports, Vol.15(1), 24566
2025
DOI: https://doi.org/10.1038/s41598-025-10149-0
PMID: 40628904
pdf
Published3.71 MBDownloadView
CC BY-NC-ND V4.0,  Open Access

Abstract

Adolescent Adult Aged Child Child, Preschool COVID-19 - epidemiology Denmark - epidemiology Female Humans Infant Male Middle Aged Multilocus Sequence Typing Phylogeny Pneumococcal Infections - epidemiology Pneumococcal Infections - microbiology Pneumococcal Infections - prevention & control Pneumococcal Vaccines - immunology Serogroup Serotyping Streptococcus pneumoniae - classification Streptococcus pneumoniae - genetics Streptococcus pneumoniae - isolation & purification Whole Genome Sequencing Young Adult
Denmark has monitored invasive pneumococcal diseases (IPD) for decades, observing shifts in serotype prevalence, partly due to pneumococcal conjugate vaccines in children. The COVID-19 pandemic and the Danish government's 2020 vaccination program with the 23-valent pneumococcal polysaccharide vaccine (PPV23) for older adults further influenced IPD epidemiology. This study explores the dynamics of Global Pneumococcal Sequence Clusters (GPSCs) in Denmark from 2019 to 2023 using whole-genome sequencing (WGS) on IPD isolates from all age groups received at Statens Serum Institut (SSI). Serotyping, multilocus sequence typing (MLST), GPSC identification, and phylogenetic analysis to assess clonal relationships were conducted. Of the 1,999 sequenced isolates, representing 93.3% of reported cases, 79 different GPSCs were identified, with GPSC3, GPSC12, and GPSC19 being dominant. GPSC3/ST53 (serotype 8) declined significantly from 24.6% in 2019 to 14.4% in 2023 (p < 0.05), whereas GPSC12/ST180 (serotype 3) increased significantly from 8.2% to 15.1% (p < 0.05). The PPV23 vaccine and pandemic restrictions decreased IPD incidence, particularly for vaccine-covered serotypes, yet serotype 3 remained problematic, indicating challenges in achieving broad serotype coverage. Although pneumococcal vaccination and pandemic-related public health measures influenced the distribution of serotypes and sequence types (STs), only two dominant GPSCs showed clear changes over time. This reflects that a single GPSC can encompass multiple serotype-ST combinations, including both vaccine-covered and non-vaccine variants. As a result, while GPSCs provide a useful high-level overview of pneumococcal lineages, they may lack the resolution needed to detect finer-scale shifts in serotype-ST composition, especially those critical for evaluating vaccine impact and identifying emerging clones.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

43 File views/ downloads
11 Record Views
1 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.23 Antibiotics & Antimicrobials
1.23.347 Streptococcus Pneumoniae
Web Of Science research areas
Microbiology
ESI research areas
Immunology
Logo image